Submission Details
| 510(k) Number | K251024 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 02, 2025 |
| Decision Date | April 30, 2025 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K251024 is an FDA 510(k) clearance for the TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge, a System, Multipurpose For In Vitro Coagulation Studies (Class II — Special Controls, product code JPA), submitted by Haemonetics (Boston, US). The FDA issued a Cleared decision on April 30, 2025, 28 days after receiving the submission on April 2, 2025. This device falls under the Hematology review panel. Regulated under 21 CFR 864.5425.
| 510(k) Number | K251024 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 02, 2025 |
| Decision Date | April 30, 2025 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | JPA — System, Multipurpose For In Vitro Coagulation Studies |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.5425 |